These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 886680)

  • 1. [Side-effects of antituberculous drugs observed in five different regimens (author's transl)].
    Aizawa H; Sakai K; Kishida K
    Kekkaku; 1977 May; 52(5):229-34. PubMed ID: 886680
    [No Abstract]   [Full Text] [Related]  

  • 2. [Side effects of antituberculous drugs observed within six months after admission. Tuberculosis Research Committee, Ryoken (author's transl)].
    Kekkaku; 1975 Jun; 50(6):161-7. PubMed ID: 1185917
    [No Abstract]   [Full Text] [Related]  

  • 3. [Short-course chemotherapy for pulmonary tuberculosis (author's transl)].
    Yamamoto K
    Kekkaku; 1978 Aug; 53(8):401-6. PubMed ID: 703041
    [No Abstract]   [Full Text] [Related]  

  • 4. [A survey on the duration of chemotherapy for pulmonary tuberculosis patients in Japan (author's transl)].
    Kekkaku; 1978 Sep; 53(9):471-6. PubMed ID: 713226
    [No Abstract]   [Full Text] [Related]  

  • 5. Drugs for tuberculosis.
    Med Lett Drugs Ther; 1986 Jan; 28(705):6-8. PubMed ID: 3941657
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experimental model of the short-course chemotherapy (author's transl)].
    Toyohara M
    Kekkaku; 1979 Jul; 54(7):369-74. PubMed ID: 513435
    [No Abstract]   [Full Text] [Related]  

  • 7. [Surveillance of adverse effects of antituberculous therapy upon the liver (author's transl)].
    Estay S; Armas Merino R; Busel I; Baier E; Wolff C; Jabsa Z
    Rev Med Chil; 1981 Mar; 109(3):212-20. PubMed ID: 7280406
    [No Abstract]   [Full Text] [Related]  

  • 8. [Direct and late results of the treatment of severe cases of primary tuberculosis by Pronisone and antituberculous drugs (author's transl)].
    Djurić-Milosavljević O; Moskovljević D
    Plucne Bolesti Tuberk; 1979; 31(3-4):125-9. PubMed ID: 538114
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of tuberculosis].
    Eier A; Grass S
    Wien Med Wochenschr; 1994; 144(8-9):186-8. PubMed ID: 7941607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of tuberculosis with a transient aggravation during initial phase of chemotherapy (author's transl)].
    Kishimoto H; Kawachi H; Shimokata K
    Kekkaku; 1982 Feb; 57(2):95-8. PubMed ID: 7069978
    [No Abstract]   [Full Text] [Related]  

  • 11. [Administration of antituberculous drugs to subjects with basic diseases. 3. Clinical studies on the side effects of antituberculous drugs in patients with or without basic diseases, especially drug allergy].
    Onaka A
    Kekkaku; 1987 Dec; 62(12):672-5. PubMed ID: 3448353
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation of the effectiveness of different combinations of antituberculosis drugs in the treatment of pulmonary TB (author's transl].
    Zorić M; Jarebica M; Teofanović D; Toula Z; Milicević N
    Plucne Bolesti Tuberk; 1977; 29(3-4):207-17. PubMed ID: 609627
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experimental studies on the effective regimens of antituberculous drugs in the treatment of tuberculosis. II. Long-term chemotherapy in mice by daily and intermittent administration with changing drug combination (author's transl)].
    Kondo E; Kanai K
    Kekkaku; 1977 Aug; 52(8):373-6. PubMed ID: 916488
    [No Abstract]   [Full Text] [Related]  

  • 14. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)].
    Kekkaku; 1980 Jan; 55(1):7-13. PubMed ID: 6988627
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of tuberculosis. Drug combinations, therapeutic problems and results in a 10-year case load].
    Morland L
    Tidsskr Nor Laegeforen; 1990 Nov; 110(28):3608-11. PubMed ID: 2260057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adverse reactions of antituberculous agents, especially about its onset and duration].
    Yamada H; Yasuoka A; Sasayama K; Doutsu Y; Hayashi T; Kohno S; Yamaguchi K; Hirota M; Hara K
    Kekkaku; 1990 Sep; 65(9):563-8. PubMed ID: 2232434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Seminar: discussion on the chemotherapy of pulmonary tuberculosis and related problems (author's transl)].
    Shen ZL
    Zhonghua Nei Ke Za Zhi; 1980 Nov; 19(6):472-5. PubMed ID: 7297271
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical trials on chemotherapy of tuberculosis in Chile (author's transl)].
    Farga V
    Rev Med Chil; 1981 Aug; 109(8):769-73. PubMed ID: 7043693
    [No Abstract]   [Full Text] [Related]  

  • 19. Adverse reactions in the conditions of an ab initio intermittent (2/7) administration of antituberculous regimens.
    Corlan E
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(2):169-72. PubMed ID: 2999959
    [No Abstract]   [Full Text] [Related]  

  • 20. [Controversy over tuberculosis therapy in HIV infected patients. Isoniazide therapy--brief chemotherapy].
    Arnheim K
    Fortschr Med; 1995 Dec; 113(35-36):14-5. PubMed ID: 8582689
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.